Eli Lilly (United Kingdom) (Q333254): Difference between revisions

From geokb

Latest revision as of 15:08, 10 September 2024

company organization in Basingstoke, United Kingdom

Language	Label	Description	Also known as
English	Eli Lilly (United Kingdom)	company organization in Basingstoke, United Kingdom

Statements

0 references

addresses subject

Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders

253

1 reference

https://openalex.org/I4210095227

Schizophrenia Research and Treatment

153

1 reference

https://openalex.org/I4210095227

Health Economics and Quality of Life Assessment

151

1 reference

https://openalex.org/I4210095227

Management of Diabetes Mellitus and Cardiovascular Risk

142

1 reference

https://openalex.org/I4210095227

Mechanisms of Alzheimer's Disease

134

1 reference

https://openalex.org/I4210095227

Structure and Function of G Protein-Coupled Receptors

116

1 reference

https://openalex.org/I4210095227

Molecular Mechanisms of Depression Treatment Strategies

107

1 reference

https://openalex.org/I4210095227

Management of Diabetes Mellitus and Hypoglycemia

106

1 reference

https://openalex.org/I4210095227

Epidemiology and Management of Bipolar Disorder

85

1 reference

https://openalex.org/I4210095227

Computational Methods in Drug Discovery

74

1 reference

https://openalex.org/I4210095227

Advancements in Lung Cancer Research

73

1 reference

https://openalex.org/I4210095227

Attention-Deficit/Hyperactivity Disorder

70

1 reference

https://openalex.org/I4210095227

Molecular Mechanisms of Ion Channels Regulation

69

1 reference

https://openalex.org/I4210095227

Structure and Function of Nicotinic Receptors

68

1 reference

https://openalex.org/I4210095227

Neurobiological Mechanisms of Drug Addiction and Depression

65

1 reference

https://openalex.org/I4210095227

Diagnosis and Management of Alzheimer's Disease

61

1 reference

https://openalex.org/I4210095227

Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer

54

1 reference

https://openalex.org/I4210095227

Cholinesterase Inhibitors in Neurodegenerative Diseases

54

1 reference

https://openalex.org/I4210095227

Role of Microglia in Neurological Disorders

52

1 reference

https://openalex.org/I4210095227

Peptide Synthesis and Drug Discovery

49

1 reference

https://openalex.org/I4210095227

Neural Mechanisms of Memory Formation and Spatial Navigation

47

1 reference

https://openalex.org/I4210095227

Advancements in Colorectal Cancer Research

47

1 reference

https://openalex.org/I4210095227

Analysis of Brain Functional Connectivity Networks

45

1 reference

https://openalex.org/I4210095227

Statistical Methods in Clinical Trials and Drug Development

43

1 reference

https://openalex.org/I4210095227

Developmental Pharmacology in Pediatric Drug Use

43

1 reference

https://openalex.org/I4210095227

coordinate location

51°16'43"N, 1°6'20"W

1 reference

https://openalex.org/I4210095227

United Kingdom of Great Britain and Northern Ireland

1 reference

https://openalex.org/I4210095227

official website

http://www.lilly.co.uk/en/index.aspx

1 reference

https://openalex.org/I4210095227

0 references

Research Organization Registry ID

0 references

is subsidiary of

Eli Lilly (United States)

1 reference

https://openalex.org/I4210095227

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q333254&oldid=1269665"